Patents by Inventor Douglas Hovey

Douglas Hovey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20150320682
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: May 15, 2015
    Publication date: November 12, 2015
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 9107827
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: August 18, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 9101540
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: August 11, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 9101549
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: August 11, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 9044396
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: June 2, 2015
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 9040088
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: May 26, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20150086635
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: November 7, 2014
    Publication date: March 26, 2015
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20150056287
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: November 7, 2014
    Publication date: February 26, 2015
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20150056286
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: November 7, 2014
    Publication date: February 26, 2015
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20120087955
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: October 7, 2011
    Publication date: April 12, 2012
    Inventors: Douglas HOVEY, John Pruitt, Tuula Ryde
  • Nanoparticulate statin formulations and novel statin combinations
    Publication number: 20110027371
    Abstract: The present invention is directed to nanoparticulate compositions comprising statin such as lovastatin or simvastatin. The statin particles of the composition have an effective average particle size of less than about 2000 nm. In another aspect of this invention, novel combinations of statins and other cholesterol lowering agents are described and methods of using same are taught.
    Type: Application
    Filed: March 6, 2006
    Publication date: February 3, 2011
    Inventors: Eugene R. Cooper, Douglas Hovey, Greta Cary, Marie Lindner, Elaine Liversidge, Gary G. Liversidge, Tuula Ryde
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20100266705
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: June 29, 2010
    Publication date: October 21, 2010
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Publication number: 20100226989
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: June 22, 2006
    Publication date: September 9, 2010
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate statin formulations and novel statin combinations
    Publication number: 20080213378
    Abstract: The present invention is directed to nanoparticulate compositions comprising statin such as lovastatin or simvastatin. The statin particles of the composition have an effective average particle size of less than about 2000 nm. In another aspect of this invention, novel combinations of statins and other cholesterol lowering agents are described and methods of using same are taught.
    Type: Application
    Filed: October 31, 2007
    Publication date: September 4, 2008
    Inventors: Eugene R. Cooper, Douglas Hovey, Greta Cary, Marie Lindner, Elaine Liversidge, Gary G. Liversidge, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Publication number: 20080171088
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: October 31, 2007
    Publication date: July 17, 2008
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 7101576
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: April 14, 2003
    Date of Patent: September 5, 2006
    Assignee: Elan Pharma International Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE COMPOSITIONS OF MITOGEN-ACTIVATED PROTEIN (MAP) KINASE INHIBITORS
    Publication number: 20060193920
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: December 7, 2005
    Publication date: August 31, 2006
    Inventors: H. Bosch, Greta Cary, Douglas Hovey, Rajeev Jain, Laura Kline, Elaine Merisko-Liversidge, Kevin Ostrander
  • Nanoparticulate megestrol formulations
    Publication number: 20050233001
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: March 30, 2005
    Publication date: October 20, 2005
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Novel compositions of sildenafil free base
    Publication number: 20050042177
    Abstract: The present invention is directed to nanoparticulate compositions comprising sildenafil free base. The sildenafil free base particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: July 21, 2004
    Publication date: February 24, 2005
    Inventors: Tuula Ryde, Douglas Hovey, H. Bosch
  • Nanoparticulate megestrol formulations
    Publication number: 20050008707
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: June 29, 2004
    Publication date: January 13, 2005
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde